Related Experiment Videos
Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470
1Department of Surgery I, School of Medicine, Kanazawa University, Japan.
Abstract:
We assessed the inhibitory action of TNP-470 on lymph node metastasis in a metastatic model system using athymic nude mice. Mice were injected subcutaneously with 5 x 10(6) HT-1080 cells in the right groin. TNP-470 (10, 30 and 100 mg kg-1) was injected subcutaneously nine times in total every other day from the 7th day after tumour inoculation. Axillar and inguinal lymph nodes were dissected, and DNA was extracted 5 weeks after tumour inoculation. Specific detection of a human beta-globin-related sequence in metastasized human tumour cells in nude mice was done by the polymerase chain reaction (PCR) technique and analysed by Southern blotting. Anti-tumour effects on primary sites were seen only in the 100 mg kg-1 treatment group. Lymph node metastasis of transplanted HT-1080 cells was seen in all mice of the no treatment group (5/5). On the other hand, incidences of lymph node metastasis in treated mice were 2/4 mice (100 mg kg-1, 2/5 mice (30 mg kg-1) and 4/5 mice (10 mg kg-1). The inhibition ratios of lymph node metastasis were 82.3% at 10 mg kg-1, 97.2% at 30 mg kg-1 and 97.5% at 100 mg kg-1 respectively. This agent may be useful to inhibit lymph node metastasis.
Insights
TNP-470 effectively inhibited lymph node metastasis in a mouse model. This anti-cancer agent demonstrated significant efficacy in preventing the spread of HT-1080 tumor cells to lymph nodes.
Area of Science:
- Oncology
- Pharmacology
- Cancer Metastasis Research
Background:
- Lymph node metastasis is a critical factor in cancer progression and patient prognosis.
- Developing effective therapeutic strategies to inhibit metastasis remains a significant challenge in cancer treatment.
Purpose of the Study:
- To evaluate the inhibitory effect of TNP-470 on lymph node metastasis.
- To assess the efficacy of TNP-470 in a preclinical model of cancer metastasis.
Main Methods:
- A metastatic model system using athymic nude mice injected with HT-1080 cells was established.
- TNP-470 was administered at various doses (10, 30, 100 mg kg-1) over a period of time.
- Polymerase chain reaction (PCR) and Southern blotting were used to detect and quantify human tumor cells in lymph nodes.
Main Results:
- TNP-470 demonstrated significant inhibition of lymph node metastasis at all tested doses.
- Inhibition ratios ranged from 82.3% to 97.5%, with higher doses showing greater efficacy.
- Anti-tumor effects on primary sites were observed only at the highest TNP-470 dose (100 mg kg-1).
Conclusions:
- TNP-470 is a potent inhibitor of lymph node metastasis.
- This agent holds promise as a therapeutic option for preventing cancer spread to lymph nodes.